West Pharmaceutical Services, Inc. to Acquire Medimop Medical Projects Ltd.
Advertisement
West Pharmaceutical Services, Inc., a global market leader in closure systems and syringe components for use with injectable drugs, announced the acquisition of 90% of privately-held and Israel-based Medimop Medical Projects, Ltd., a leading developer and supplier of disposable medical devices for the mixing, transfer, reconstitution and administration of injectable drugs.
Medimop provides customers with technologies and systems for the reconstitution, transfer and administration of pharmaceutical products in therapeutic areas including multiple sclerosis, rheumatoid arthritis, vaccines, hormones and blood derivatives for haemophilia. Many drug products, including the majority of recently introduced biotechnology products, require reconstitution at the point of use because they are produced as freeze-dried powders in order to preserve product efficacy during shipment and storage.
Topics
Organizations
Other news from the department business & finance

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.